Remote ischemic preconditioning for prevention of contrast-associated acute kidney injury following percutaneous coronary intervention: a randomized controlled trial
Clinical Kidney Journal · 01.12.2025 · 18 (12)
DOI: 10.1093/ckj/sfaf342 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Kidney Journal, online erschienen am 07.11.2025. Verfasst von Ganesh Paramasivam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Background
Contrast-associated acute kidney injury (CA-AKI) has been reported to occur in a significant proportion of patients undergoing percutaneous coronary intervention (PCI). The role of remote ischemic preconditioning (RIPC) in CA-AKI prevention remains unclear.
Methods
In this single-center double-blind randomized controlled trial, 420 eligible patients with high risk of CA-AKI admitted for PCI were randomized into two groups: RIPC and sham RIPC (control group). RIPC was performed by repeated cycles of inflation and deflation of an upper limb blood pressure cuff prior to PCI. Serum neutrophil gelatinase-associated lipocalin (NGAL) levels were measured at 2- and 6-h, and serum creatinine at 24- and 48-h post-PCI. The primary endpoint was the incidence of CA-AKI. Secondary endpoints were change in serum creatinine at 48 h, incidence of subclinical AKI (defined as an increase in NGAL values by 25% or more from baseline), change in NGAL at 2- and 6-h (delta NGAL), in-hospital mortality and major adverse cardiovascular events (MACE) at Day 30.
Results
CA-AKI occurred in 11.4% (n = 48), with AKI stage 1 in 10.2% (n = 42). The incidence of CA-AKI was significantly lower in the RIPC group, compared with control group [8.1% vs 15.0%, risk ratio (RR) 0.54, 95% confidence interval (CI) 0.31–0.94; P = .027]. There was no significant difference in change in creatinine at 48 h in both the groups (P = .158). The incidence of subclinical AKI was also numerically lower in the RIPC group; however, this was not statistically significant (36.2% vs 40.5%, RR 0.89, 95% CI 0.66–1.22; P = .158). Dialysis-requiring AKI, in-hospital mortality and 30-day MACE were similar in both groups. There were no RIPC-related adverse events.
Conclusions
In patients at high risk of developing CA-AKI after PCI, RIPC is an effective and safe preventive measure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
- Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
- Department of Biochemistry, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.
ORCID-Profile: Ganesh Paramasivam, Indu Ramachandra Rao
Förderung
- Indian Council of Medical Research
Zitieren
APA
Paramasivam, G., Bangera, A., Kolakemar, A., Acharya, S., Maradi, R., Nagaraju, S. P., Ramachandran, P., Devasia, T., Prabhu, A. R., & Rao, I. R. (2025). Remote ischemic preconditioning for prevention of contrast-associated acute kidney injury following percutaneous coronary intervention: a randomized controlled trial. Clinical Kidney Journal, 18(12). https://doi.org/10.1093/ckj/sfaf342
Vancouver
Paramasivam G, Bangera A, Kolakemar A, Acharya S, Maradi R, Nagaraju SP, et al. Remote ischemic preconditioning for prevention of contrast-associated acute kidney injury following percutaneous coronary intervention: a randomized controlled trial. Clinical Kidney Journal. 2025;18(12). doi:10.1093/ckj/sfaf342
BibTeX
@article{Paramasivam2025,
author = {Paramasivam, Ganesh and Bangera, Ashika and Kolakemar, Ashwija and Acharya, Shravana and Maradi, Ravindra and Nagaraju, Shankar Prasad and Ramachandran, Padmakumar and Devasia, Tom and Prabhu, Attur Ravindra and Rao, Indu Ramachandra},
title = {Remote ischemic preconditioning for prevention of contrast-associated acute kidney injury following percutaneous coronary intervention: a randomized controlled trial},
journal = {Clinical Kidney Journal},
year = {2025},
volume = {18},
number = {12},
doi = {10.1093/ckj/sfaf342}
}
EUVIMED